Stay updated on Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added collaborator/institution details: Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, along with a 'Helpful Links Provided by' section.
    Difference
    0.6%
    Check dated 2025-11-03T21:10:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the sponsor/institution entry (Alvin J. Siteman Cancer Center at Barnes‑Jewish Hospital and Washington University School of Medicine) and the 'Helpful Links Provided by' section from the Study Details page.
    Difference
    0.2%
    Check dated 2025-10-27T19:06:45.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:35:02.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated page version to v3.1.0 and removed a specific resource entry for Head and neck squamous cell carcinoma.
    Difference
    0.5%
    Check dated 2025-09-29T03:06:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:13:32.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T15:39:12.000Z thumbnail image

Stay in the know with updates to Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.